Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNTI

Senti Biosciences (SNTI)

Senti Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNTI
DateTimeSourceHeadlineSymbolCompany
05/29/20243:14PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNTISenti Biosciences Inc
05/29/20243:09PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNTISenti Biosciences Inc
05/29/20243:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNTISenti Biosciences Inc
05/17/20244:19PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNTISenti Biosciences Inc
05/17/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNTISenti Biosciences Inc
05/13/20247:15AMGlobeNewswire Inc.Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
05/09/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNTISenti Biosciences Inc
05/09/20243:05PMGlobeNewswire Inc.Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate HighlightsNASDAQ:SNTISenti Biosciences Inc
04/30/20247:05AMGlobeNewswire Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)NASDAQ:SNTISenti Biosciences Inc
03/21/20243:05PMGlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
01/05/20243:05PMGlobeNewswire Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical ProgramNASDAQ:SNTISenti Biosciences Inc
12/22/20235:30AMGlobeNewswire Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
11/13/20233:15PMGlobeNewswire Inc.Senti Bio Announces Third Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
11/06/20233:05PMGlobeNewswire Inc.Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in ChinaNASDAQ:SNTISenti Biosciences Inc
10/31/20238:06AMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual MeetingNASDAQ:SNTISenti Biosciences Inc
09/27/20238:05AMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 MeetingNASDAQ:SNTISenti Biosciences Inc
09/26/20233:05PMGlobeNewswire Inc.Senti Bio to Participate in Upcoming ConferencesNASDAQ:SNTISenti Biosciences Inc
09/05/20237:30AMGlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
08/11/20237:35AMGlobeNewswire Inc.Senti Bio Announces Second Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
08/10/20237:35AMGlobeNewswire Inc.Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon PartnersNASDAQ:SNTISenti Biosciences Inc
05/20/20237:05AMGlobeNewswire Inc.Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:SNTISenti Biosciences Inc
05/09/20233:05PMGlobeNewswire Inc.Senti Bio Announces First Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
05/02/20233:45PMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual MeetingNASDAQ:SNTISenti Biosciences Inc
04/17/20237:45AMGlobeNewswire Inc.Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
04/14/20238:00AMGlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
03/22/20234:09PMGlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
03/14/20233:35PMGlobeNewswire Inc.Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
02/03/20233:05PMGlobeNewswire Inc.Senti Biosciences Announces New Employment Inducement GrantsNASDAQ:SNTISenti Biosciences Inc
02/01/20233:05PMGlobeNewswire Inc.Senti Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:SNTISenti Biosciences Inc
01/27/20237:00AMGlobeNewswire Inc.Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway GuidanceNASDAQ:SNTISenti Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SNTI

Your Recent History

Delayed Upgrade Clock